Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients

Kidney International

Volumn 65, Issue 5, 2004, Pages 1947-1955

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Poon, Peter ^a   Szeto, Carol Yi Ki ^a   Wong, Teresa Yuk Hwa ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Peritoneal dialysis; Peritoneal transport; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSATE LEVEL; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL; TRANSPORT KINETICS; TREATMENT OUTCOME;

EID: 2342538380     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00605.x     Document Type: Conference Paper

References (41)

1. LEUNG DW, CACHIANES G, KUANG WJ, et al: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989
2. ZWEERS MM, DE WAART DR, SMIT W, et al: Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 134:124-132, 1999
3. SELGAS R, DEL PESO G, BAJO MA, et al: Spontaneous VEGF production by cultured peritoneal mesothelial cells from patients on peritoneal dialysis. Perit Dial Int 20:798-801, 2000
4. COMBET S, MIYATA T, MOULIN P, et al: Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11:717-728, 2000
5. VINCENTI V, CASSANO C, ROCCHI M, PERSICO G: Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493-1495, 1996
6. BROGAN IJ, KHAN N, ISAAC K, et al: Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60:1245-1249, 1999
7. WATSON CJ, WEBB NJ, BOTTOMLEY MJ, BRENCHLEY PE: Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine 12:1232-1235, 2000
8. SHAHBAZI M, FRYER AA, PRAVICA V, et al: Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13:260-264, 2002
9. AWATA T, INOUE K, KURIHARA S, et al: A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635-1639, 2002
10. VIBERTI GC: Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. Am J Med 75:81-84, 1983
11. DE VRIESE AS, TILTON RG, STEPHAN CC, LAMEIRE NH: Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 12:1734-1741, 2001
12. TWARDOWSKI ZJ, NOLPH KD, PROWANT B, et al: Peritoneal equilibration test. Perit Dial Bull 7:138-147, 1987
13. ROCCO MV, JORDAN JR, BURKART JM: Determination of peritoneal transport characteristics with 24-hour dialysate collections: Dialysis adequacy and transport test. J Am Soc Nephrol 5:1333-1338, 1994
14. ROCCO MV, JORDAN JR, BURKART JM: 24-hour dialysate collection for determination of peritoneal membrane transport characteristics: Longitudinal follow-up data for the dialysis adequacy and transport test (DATT). Perit Dial Int 16:590-593, 1996
15. MAK TW, CHEUNG CK, CHEUNG CM, et al: Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol Dial Transplant 12:184-186, 1997
16. KREDIET RT, BOESCHOTEN EW, ZUYDERHOUDT FMJ, et al: Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purification 4:194-203, 1986
17. NOE DA: A body surface area nomogram based on the formula of Gehan and George. J Pharm Sci 80:501-502, 1991
18. SZETO CC, WONG TY, CHOW KM, et al: Dialysis adequacy and transport test for characterization of peritoneal transport type in Chinese peritoneal dialysis patients receiving three daily exchanges. Am J Kidney Dis 39:1287-1299, 2002
19. VAN OLDEN RW, KREDIET RT, STRUIJK DG, ARISZ L: Measurement of residual rneal function in patients treated with continuous peritoneal dialysis. J Am Soc Nephrol 7:745-748, 1996
20. DAVIES SJ, PHILLIPS L, NAISH PF, RUSSELL GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046-1051, 2001
21. PERREY C, TURNER SJ, PRAVICA V, et al: ARMS-PCR technologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta1 gene polymorphisms. Transplant Immunol 7:127-128, 1999
22. LAI KN, LAI KB, SZETO CC, et al: Growth factors in continuous ambulatory peritoneal dialysis effluent - Their relation with peritoneal transport of small solutes. Am J Nephrol 19:416-422, 1999
23. RUBIN DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127:757-763, 1997
24. LI PK, CHOW KM, WONG TY, et al: Effects of an angiotensin converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis: A prospective randomized study. Ann Intern Med 139:105-112, 2003
25. CANADA-USA (CANUSA) PERITONEAL DIALYSIS STUDY GROUP: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1996
26. SZETO CC, WONG TY, LEUNG CB, et al: Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58:400-407, 2000
27. GUNAL A, CELIKER H, AKPOLAT N, et al: By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution. Perit Dial Int 22:301-306, 2002
28. SEO MJ, OH SJ, KIM SI, et al: High glucose dialysis solutions increase synthesis of vascular endothelial growth factors by peritoneal vascular endothelial cells. Perit Dial Int 21 (Suppl 3):S35-S40, 2001
29. DE VRIESE AS, TILTON RG, STEPHAN CC, LAMEIRE NH: Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 12:1734-1741, 2001
30. HA H, CHA MK, CHOI HN, LEE HB: Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22:171-177, 2002
31. MANDL-WEBER S, COHEN CD, HASLINGER B, et al: Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 61:570-578, 2002
32. PECOITS-FILHO R, ARAUJO MR, LINDHOLM B, et al: Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17:1480-1486, 2002
33. MARGETTS PJ, KOLB M, Yu L, et al: A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit Dial Int 21 (Suppl 3):S368-S372, 2001
34. POON RT, FAN ST, WONG J: Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19:1207-1225, 2001
35. KARAYIANNAKIS AJ, SYRIGOS KN, POLYCHRONIDIS A, et al: Circulating VEGF levels in the serum of gastric cancer patients: Correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 236:37-42, 2002
36. WERTHER K, CHRISTENSEN IJ, NIELSEN HJ: Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer 86:417-423, 2002
37. STOMPOR T, ZDZIENICKA A, MOTYKA M, et al: Selected growth factors in peritoneal dialysis: Their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport. Perit Dial Int 22:670-676, 2002
38. CHURCHILL DN, THORPE KE, NOLPH KD, et al: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9:1285-1292, 1998
39. SZETO CC, LAW MC, WONG TY, et al: Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: A 2-year prospective study. Am J Kidney Dis 37:329-336, 2001
40. WITZENBICHLER B, ASAHARA T, MUROHARA T, et al: Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153:381-394, 1998
41. ISNER JM, LOSORDO DW: Therapeutic angiogenesis for heart failure. Nat Med 5:491-492, 1999